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The two-component BvrS/BvrR system is essential for Brucella abortus virulence. It was shown previously
that its dysfunction abrogates expression of some major outer membrane proteins and increases bactericidal
peptide sensitivity. Here, we report that BvrS/BvrR mutants have increased surface hydrophobicity and
susceptibility to killing by nonimmune serum. The bvrS and bvrR mutant lipopolysaccharides (LPSs) bound
more polymyxin B, chimeras constructed with bvrS mutant cells and parental LPS showed augmented poly-
myxin B resistance, and, conversely, parental cells and bvrS mutant LPS chimeras were more sensitive and
displayed polymyxin B-characteristic outer membrane lesions, implicating LPS as being responsible for the
phenotype of the BvrS/BvrR mutants. No qualitative or quantitative changes were detected in other envelope
and outer membrane components examined: periplasmic (1-2) glucans, native hapten polysaccharide, and
phospholipids. The LPS of the mutants was similar to parental LPS in O-polysaccharide polymerization and
fine structure but showed both increased underacylated lipid A species and higher acyl-chain fluidity that
correlated with polymyxin B binding. These lipid A changes did not alter LPS cytokine induction, showing that
in contrast to other gram-negative pathogens, recognition by innate immune receptors is not decreased by these
changes in LPS structure. Transcription of Brucella genes required for incorporating long acyl chains into lipid
A (acpXL and lpxXL) or implicated in lipid A acylation control (bacA) was not affected. We propose that in
Brucella the outer membrane homeostasis depends on the functioning of BvrS/BvrR. Accordingly, disruption
of BvrS/BvrR damages the outer membrane, thus contributing to the severe attenuation manifested by bvrS and
bvrR mutants.
Bacteria are able to survive in different environments by
modulating the expression of their genes. This attribute is
often accomplished by two-component transduction systems
that assemble both sensors and regulators (46). Brucella organ-
isms are intracellular -Proteobacteria found in mammalian
body fluids and within mammalian cells (52). Although ge-
nome sequencing has revealed 21 putative two-component reg-
ulatory systems in the Brucella genus (13, 40, 56), one of the
best-characterized two-component systems involved in viru-
lence is the BvrS/BvrR system. Indeed, the bvrS and bvrR
mutants are avirulent in mice (63), show reduced invasiveness
to epithelial cells and macrophages, and are incapable of in-
hibiting lysosome fusion and replicating intracellularly (42, 63).
Dysfunction of BvrS and BvrR also diminishes the character-
istic resistance of Brucella to bactericidal cationic peptides and
increases its permeability to surfactants (63). Since the viru-
lence of Brucella depends in part on its outer membrane (OM)
properties (20, 44, 45, 55), we proposed that the BvrS/BvrR
system plays a role in the homeostasis of the bacterial surface
as well as in setting up the structures required for parasitism
(42, 51). The B. abortus BvrS/BvrR system regulates transcrip-
tion of at least two major outer membrane proteins (Omps)
(30): a previously undescribed Omp (Omp22 or Omp3b) and
Omp25 (also named Omp3a), which has been implicated in
virulence (15, 16, 17). All other known Omps expressed in
virulent Brucella abortus are detected to a similar level in the
bvrS and bvrR mutants and the wild-type (wt) bacteria (30).
However, although they are slightly attenuated, B. abortus
omp25 and omp22 mutants do not show the high level of
attenuation and sensitivity to bactericidal peptides displayed by
the bvrS and bvrR mutants (15; Lo´pez-Gon˜i et al., unpublished
results). Therefore, it seems that other factors linked to viru-
lence are regulated by the BvrS/BvrR system. In this study, we
have investigated non-protein envelope molecules in the bvrS
and bvrR mutants and discovered modifications in their lipo-
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polysaccharide (LPS) lipid A moieties. We also found that the
overall surface hydrophobicity of the envelope was altered and
that recognition by complement in the absence of antibodies
was enhanced. These results give clear new insights to explain
the defective virulent phenotype of bvrS and bvrR mutants.
MATERIALS AND METHODS
Bacterial strains and growth conditions. B. abortus 2308 (parental wild-type
virulent strain), B. abortus 2.13 (bvrS::Tn5 mutant, avirulent), B. abortus 65.21
(bvrR::Tn5 mutant, avirulent) and B. abortus 65.21p (bvrR::Tn5 mutant recon-
stituted, strain 65.21 with plasmid pBBR1MCS-4 bvrR) (30, 63) were routinely
grown in standard tryptic soy broth or agar, either plain or with the appropriate
antibiotics. For extraction of cell envelope components, bacteria were propa-
gated in a 15-liter Biostat fermentor (B. Braun Melsungen AG, Leinfelden,
Germany) as described elsewhere (1). B. abortus per, wa**, and manBcore mu-
tants are Tn5 mutants carrying rough LPSs with a complete core and a defective
inner core and outer core, respectively (49).
Extraction and purification of Brucella cell envelope components. Free lipids,
LPSs, and polysaccharides were purified from dry bacteria or from OM frag-
ments (23) following standard methods. LPSs were obtained from the phenol
phase from water-phenol extracts (38) and extensively purified (1, 53), and free
lipids were removed by extraction with chloroform-methanol (68), to yield prep-
arations composed of smooth (80%)- and rough (20%)-type LPSs (21). Lipid A’s
were obtained by LPS hydrolysis in 1% sodium-dodecyl-sulfate (SDS), 10 mM
sodium acetate (pH 4.5) at 100°C for 1 h; repeatedly washed first with ethanol-20
mM HCl and then with water; and freeze-dried (28). O-polysaccharides and core
oligosaccharides were extracted by mild acid hydrolysis (1), and, after removal of
the insoluble lipid A, they were separated on a Bio-Gel P2 (Bio-Rad) column
(21). Native hapten (NH) polysaccharide, cyclic (1-2) glucans, and total free
lipids (mainly phospholipids) were extracted as described before (1, 4, 21).
Characterization of Brucella cell envelope components. LPSs were analyzed by
unidimensional polyacrylamide gel electrophoresis with SDS (36), deoxycholate
(35), or Tricine-SDS (39, 61) or by two-dimensional gel electrophoresis (30) and
stained by the periodate-alkaline silver method (66). The level of 3-deoxy-D-
manno-2-octulosonic acid (Kdo) was measured by the thiobarbituric acid method
(1). Western blots (49) were developed with antibodies from Brucella-infected
bovines or rabbits immunized with B. abortus per, wa**, or manBcore mutants
(49). Monoclonal antibodies against O-polysaccharide epitopes (anti-C, A76/
07F09/B10; and anti-C/Y, A53/18H08/A02 and 04F9), core oligosaccharide (an-
ti-R, A68/24G12/A08; anti-outer core, Baro-1; and anti-inner core, Baro-2) and
lipid A (anti-lipid A, Bala-1, Bala-5, and Bala-13) (5, 21) were also used. O-
polysaccharides, NH-polysaccharides, cyclic (1-2) glucans, core oligosaccha-
rides, lipid A’s, and total free lipids were analyzed by high-performance thin-
layer chromatography (HPTLC) on precoated silica gel plates (E. Merck,
Darmstadt, Germany) (1, 21, 65). To determine the degree of lipid A acylation,
samples were dissolved in chloroform-methanol-ammonium-water (25:14:1:2)
and chromatographed on HPTLC plates. Plates were soaked in methanol-sulfu-
ric acid and developed as described before (49). Lipid A preparations of Esch-
erichia coli W3110 MLK3 (W3110 htrB1::Tn10, hexaacylated), W3110 MLK1067
(W3110 msbB::cam, pentaacylated), and W3110 MLK986 (MLK53
msbB::cam, tetraacylated) were used as standards (10). The structure of poly-
saccharide molecules was determined by 13C-nuclear magnetic resonance
(NMR) and 1H-NMR in an Avance Bruker 400 Ultrashield spectrometer
(Bruker Analytische Messtechnik) at 400 MHz. The amounts of O- and NH-
polysaccharides were measured in a gel immunodiffusion test (1).
Action of polycationic bactericidal peptides on LPS chimeras and binding to
LPS. To establish the role of the various LPSs in the susceptibility to these
agents, chimeras were constructed by inserting heterologous LPS (previously
homogenized by sonication and sterilized in the autoclave) in the Brucella OMs
(20). Fresh B. abortus cells were mixed with the same volume of heterologous
LPS, and the mixtures were incubated for 18 h at 40°C. Cells were washed
repeatedly to remove unbound LPS, resuspended in buffer, and tested immedi-
ately. Controls treated with plain broth were run in parallel. For the sensitivity
test, chimeras and controls were incubated for 20 min at 37°C with polymyxin B
or lactoferricin and CFU were counted on tryptic soy agar after 3 days at 37°C.
Assays were done in triplicate, and the percentage of CFU was calculated with
respect to that of controls incubated with no peptide. Microscopic observations
were performed using a Hitachi 1100 transmission electron microscope (Hitachi
Scientific Instruments, Mountain View, CA) operating at 100 kV (20).
To assess bactericidal peptide binding, LPSs were dispersed by sonication in
2.5 mM HEPES (pH 7.2) at 4 nmol Kdo/ml and incubated with different con-
centrations of dansyl-polymyxin B (62). The fluorescence was measured in con-
tinuous 400- to 600-nm scans in an LS-50 fluorimeter (Perkin-Elmer Ltd., Bea-
consfield, England) (excitation, 340 nm; 2.5-nm slit width for both windows) at
room temperature. The results were expressed as relative fluorescence units
(RFU) of the maximum of the emission peak (from 470 to 490 nm, depending on
the blue shift associated with the intensity of binding).
Determination of the acyl-chain fluidity of LPS. The transition of the acyl
chains of LPS from a well-ordered state (gel phase) to a fluid state (liquid
crystalline phase) at a lipid-specific temperature was determined by Fourier
transform infrared spectroscopy. A specific vibrational band, the symmetric
stretching vibration of the methylene groups s(CH2) around 2,850 cm1, was
analyzed since its peak position is a measure of the state of order (fluidity) of the
acyl chains (6). Measurements were performed in a Bruker IFS 55 apparatus
(Bruker, Karlsruhe, Germany) as described previously (6). To ensure homoge-
neity, LPS suspensions were prepared in 2.5 mM HEPES (pH 7.2) at room
temperature, incubated at 56°C for 15 min, stirred, and cooled to 4°C. This
heating/cooling step was repeated three times, and the suspensions were stored
at 4°C for several hours before analysis. LPS suspensions (water content, 90%)
were analyzed in CaF2 cuvettes with 12.5-m Teflon spacers, and for each
measurement, 50 interferograms were accumulated, Fourier transformed, and
converted to absorbance spectra. The measurements were obtained in continu-
ous heating scans (2°C/min) between 10°C and 60°C. To test the effect of poly-
myxin B, the experiments were performed in the presence of this lipopeptide at
various LPS/polymyxin B ratios.
Aggregate structure of LPS. The aggregate structure of lipid A’s in the absence
and presence of polymyxin B was determined by synchrotron radiation X-ray
diffraction at the European Molecular Biology Laboratory (EMBL) outstation at
the Hamburg synchrotron radiation facility HASYLAB using the double-focus-
ing monochromator-mirror camera X33 (34). X-ray diffraction patterns, ob-
tained with exposure times of 2 min using a linear gas proportional detector with
delay line readout (22), were evaluated according to previously described pro-
cedures (7). These allow assigning the spacing ratios to defined three-dimen-
sional aggregate structures, from which the conformations of the individual
molecules are deduced. In the diffraction patterns presented here, the logarithm
of the scattering intensity, log I(s), is plotted versus the scattering vector s	 2 sin

/ (2
 	 scattering angle,  	 wavelength 	 0.15 nm), and the spacings, d, are
calculated according to d 	 1/s.
Cell-surface hydrophobicity. Exponentially growing bacteria were washed
twice with 0.8 mM MgSO4, 53 mM urea in phosphate buffer (pH 7.0) and
resuspended in this solution at an optical density at 470 nm of 1.0. A volume of
this suspension was extracted with either xylene or chloroform, and the decrease
in optical density of the aqueous phase was determined (59).
RT-PCR. Total RNA was isolated from B. abortus (RNAeasy kit; QIAGEN
S.A., Courtaboeuf, France), contaminating DNA was removed (DNA-free kit,
Ambion Ltd., United Kingdom), and 1 g of RNA was reverse transcribed into
cDNA by using SuperScript III reverse transcriptase (RT; Invitrogen Life Tech-
nologies) using the random hexamers of the kit. Then, 2 l of each RT reaction
mixture was subjected to PCR using Immolase DNA polymerase (Bioline). Sense
and antisense oligonucleotide primers for RT-PCR-amplified genes were de-
signed using the Brucella melitensis genomic DNA sequence information ob-
tained from the B. melitensis Genome Database (12) and with the Primer3
program (60). Primers, synthesized by Sigma-Genosys Ltd., were as follows:
5-TAGAGCATGTTTCCGAAAA-3 and 5-AGCGCAAGACCGGCTTTCT
T-3 for open reading frame (ORF) BMEI1115 (lpxXL gene), 5-TCGCCGAA
ACCAGTGAAATC-3 and 5-CGGAACCTTGCCTTCGTTTA-3 for ORF
BMEI1111 (acpXL gene), 5-CGCGTCAAGAAAATCGTTGT-3 and 5-ACG
CCGAATTCTTCTTCAAA-3 for ORF BMEI1475 (acpXL gene), and 5-GG
CCGATTTTGCAGGCATTG-3 and 5-TCGGCAGCGTGCTGACCTTT-3
for ORF BMEI1553 (bacA gene). PCR products were analyzed on a 1.0 to 1.2%
agarose gels. Positive controls were performed with genomic DNA, and negative
controls were performed with RNA that had not been subjected to reverse
transcription.
LPS cytokine induction. To determine the level of biological activity of the
LPSs, murine C57BL/6 bone marrow-derived macrophages were tested for cy-
tokine production (69). Briefly, macrophages were allowed to adhere overnight
in 96-well plates under a 7% CO2 atmosphere at 37°C. Shigella flexneri serotype
5a (from P. Sansonetti, Institute Pasteur, France) and B. abortus LPSs were
added to the macrophages in 200 l of medium. Supernatants were collected
after 48 h and frozen until tested by enzyme-linked immunosorbent assay for
tumor necrosis factor alpha (TNF-) (R&D Systems, Minneapolis, MN), inter-
leukin-12p40 (IL-12p40) (R&D Systems), and IL-10 (BD Biosciences, San Di-
ego, CA), following the manufacturer’s instructions.
Sensitivity to the bactericidal action of nonimmune serum and LPS anticom-
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plementary activity. Exponentially growing bacteria were adjusted to 104
CFU/ml in saline and dispensed in duplicate in microtiter plates (45 l per well)
containing fresh normal calf or human serum (90 l/well). After 30 or 90 min of
incubation at 37°C, 200 l/well of brain heart infusion broth was dispensed and
mixed with the bacterial suspension and 100 l was plated on tryptic soy agar.
Results were expressed as the percentage CFU with respect to controls per-
formed with serum decomplemented at 56°C for 30 min. To assess complement
consumption, LPSs were homogenized at 250 g/ml in 0.5% triethylamine in
Veronal-Ca-Mg buffer (pH 7.5) as described for the acyl-chain fluidity analysis.
Aliquots (250 l) of these stocks were mixed with an equal volume of guinea pig
complement (BioMerieux, Marcy l’Etoile, France), diluted at 1:50 in the same
buffer, and incubated for 45 min at 37°C with gentle stirring. To measure the
amount of complement consumed, 500 l of 2% sheep erythrocytes and 0.33%
anti-sheep erythrocyte immunoglobulin G (BioMerieux) in Veronal-Ca-Mg
buffer was added, incubation was carried out for 45 min, and the hemolysis was
determined at 540 nm after removal of cells and debris by centrifugation.
RESULTS
Disruption of the bvrS and bvrR genes has no effect on
phospholipid profile or on cyclic (1-2) glucan and native
hapten polysaccharide contents. Relatively large quantities of
phosphatidylcholine, in addition to phosphatidylethanolamine
and other phospholipids, are characteristic of -Proteobacteria,
and it has been hypothesized that the unusual stability of the
Brucella OM with regard to the action of surfactants and poly-
cationic peptides may be linked to the properties of phosphati-
dylcholine (52). Therefore, it was of interest to determine the
presence of phosphatidylcholine and other phospholipids in
the cell envelopes and OM fragments of the bvrS and bvrR
mutants. No differences were observed between the phospho-
lipid profiles of the parental wild-type (wt) and mutant brucel-
lae (data not shown). Likewise, cells of -Proteobacteria con-
tain large amounts of periplasmic cyclic (1-2) glucans, which
have been implicated in Brucella virulence (8). In addition,
smooth Brucella species contain NH polysaccharide, an OM
component structurally related to the O-type polysaccharide,
and antibodies precipitating NH are a marker of infection in
animal brucellosis (14). Since it has been demonstrated that
the Sinorhizobium meliloti ExoS/ChvI system, homologous to
BvrS/BvrR (43), regulates production of extracellular polysac-
charides necessary for symbiosis (9), we also investigated cyclic
(1-2) glucans and NH production in bvrS and bvrR mutants.
Comparative quantifications of these molecules did not reveal
significant differences compared to the wt B. abortus strain
(data not shown).
The LPSs of bvrS and bvrR mutants show enhanced binding
of bactericidal cationic peptides. It is well known that LPS
contains some of the main targets for the initial binding of
polycationic bactericidal peptides to the OM (reviewed in ref-
erence 54). Accordingly, the LPSs from wt and mutant strains
were probed with one cationic peptide, dansyl-polymyxin B.
LPS from bvrS or bvrR mutant strains bound more dansyl-
polymyxin B than LPS from the parental wt strain (Fig. 1A).
The relevance of such differences was assessed using chimeras
carrying heterologous LPS in the OM. It was shown previously
using Brucella and Salmonella that such chimeras exhibit the
permeability and bactericidal cationic peptide sensitivity of the
donor bacteria (20). As illustrated in Fig. 2, chimeras of pa-
rental wt and bvrS mutant strains containing the heterologous
LPS displayed different sensitivities to polymyxin B. Insertion
of parental wt B. abortus 2308 LPS into the OM of the bvrS
mutant resulted in chimeras more resistant to polymyxin B
than the bvrS mutant. In contrast, the bvrS mutant LPS in-
serted into the OM of the parental wt B. abortus strain made
the resulting chimeras more sensitive to this antibiotic than the
wt strain (Fig. 2A). Similar results were obtained with the
microbicidal cationic peptide lactoferricin B (data not shown).
Transmission electron microscopy of LPS chimeras treated
with polymyxin B corroborated the sensitivity assays. As re-
ported before, polymyxin B did not affect the ultrastructure of
the wt B. abortus strain (20, 45, 68), whereas the B. abortus wt
2308 chimeras containing LPS of the bvrS mutant showed
morphological alterations similar to those demonstrated by the
bvrS mutant (Fig. 2B). The alterations, characterized by vacu-
ole formation, development of OM blebs, detachment of the
inner membrane and DNA condensation, were those typical of
the action of polymyxin B on gram-negative bacteria (20).
Thus, although the presence of heterologous LPS did not com-
pletely change the sensitivity of the chimeric strains due to the
presence of endogenous LPS, these experiments directly dem-
onstrated that LPS is responsible for the increased binding of
polymyxin B by bvrS and bvrR mutant strains.
The lipid A of the LPSs of bvrS and bvrR mutants, but not
the polysaccharide moiety, is modified and exhibits altered
acylation, acyl-chain fluidity, and aggregate structure. The
peptide-binding experiments suggested that BvrS/BvrR dys-
function caused LPS structural changes. However, wt and mu-
tant strains contained similar amounts of LPS and the LPS
profiles obtained after SDS-, Tricine-SDS-, deoxycholate-, or
two-dimensional polyacrylamide gel electrophoresis were
those typical of smooth brucellae and similar for both mutants
and the wt strain (not shown). No differences were observed
either when these three LPSs were tested by Western blotting
with immune sera from infected bovines or rabbits immunized
with rough mutants with progressive LPS core deficiencies or
with monoclonal antibodies against C, C/Y, LPS core, outer
core, or inner core epitopes (data not shown). Absence of
differences in the fine structure of the LPS sugar moiety was
verified further. First, 13C-NMR and 1H-NMR spectroscopy
yielded identical spectra for the O-polysaccharides obtained
from the LPSs of the parental wt and mutant strains (data not
shown). Second, the oligosaccharides obtained from the rough-
type LPSs (normally present in the LPS extracts of smooth
Brucellae) of the bvrS and bvrR mutants and the parental wt
strain showed similar migration patterns after HPTLC analysis
(data not shown), a method that reveals Brucella LPS core
heterogeneity (21).
Western blots with the monoclonal antibodies recognizing
the three epitopes in the sugar backbone of B. abortus lipid A
(58) did not reveal differences among the LPSs (data not
shown). Conspicuous differences in the heterogeneity of lipid
A molecules were, however, noted between the bvrS bvrR mu-
tants and the wt Brucella (Fig. 1). Whereas the lipid A’s from
the wt and the reconstituted bvrR strains contained two major
lipid A forms, the lipid A’s from the bvrS and bvrR mutants
showed two additional forms with lower Rfs (Fig. 1B). These
differences were more pronounced when the lipid molecules
from OM fragments were analyzed (Fig. 1B). By comparison
with E. coli lipid A molecules of known structure, a correlation
was established between the underacylated lipid A’s of E. coli
and the Brucella lipid A bands with lower Rfs.
LPSs are amphipathic molecules forming aggregates in
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aqueous solutions that mimic the external leaflet of the OM.
Thus, we examined whether the lipid A changes described
above altered the acyl-chain fluidity in LPS aggregates, a prop-
erty relevant to the overall structure and function of the OM.
To this end, we determined the temperature-dependent shifts
in the maximum peak position of the symmetric stretching
vibration s(CH2) of the acyl chains, a parameter that directly
relates to the fluidity of these chains. As illustrated in Fig. 1C,
the phase transitions were broader for the mutant LPSs, with
transition temperatures (Tc) markedly different (37°C for the
wt versus 32°C for the mutants). Moreover, for the mutant
LPSs, the corresponding peak positions—expressed as wave
number (cm1)—were markedly higher at temperatures below
Tc. These results demonstrate a higher acyl-chain fluidity in the
LPSs of the mutants. The relevance of this difference in acyl-
chain fluidity was proven when the assays were repeated in the
presence of polymyxin B. The decrease of Tc to lower values
and the higher peak positions observed with the LPSs of the
bvrS and bvrR mutants showed that polymyxin B had a stronger
effect on the LPS of the mutants (Fig. 1C). This result agrees
with the data in Fig. 1A. Measurements performed with lipid
A’s corroborated that the changes in fluidity were attributable
to this LPS moiety (data not shown).
In addition to the acyl-chain fluidity, the type of aggregate
structure formed is an important parameter for understanding
the bioactivity of LPSs (6, 7). Therefore, isolated lipid A prep-
arations from wt and mutant bvrS were analyzed by synchro-
tron radiation X-ray diffraction. Lipid A’s rather than LPSs
were used since aggregate structures of the former are usually
more readily assignable. We found that the diffraction patterns
of both lipid A samples exhibited unspecific, weak, and broad
reflections, which were difficult to interpret (data not shown).
In the presence of polymyxin B, however, the patterns were
interpretable (Fig. 1D). The lipid A aggregate structure from
the wt strain at 40°C indicated a complex diffraction pattern
with reflections ranging down to very low scattering vectors
(corresponding to low scattering angles). The existence of par-
ticular relationships between the spacings of the reflections
(for example, 7.94 nm 	 11.3 nm/2) was indicative of a cubic
aggregate structure (Fig. 1D). In contrast, the lipid A from the
bvrS mutant (Fig. 1D) showed one broad peak with only a
slightly pronounced maximum around 5.74 nm, characteristic
of a bilayer structure. It has been shown previously that the
predominant aggregate structure of biologically active native
lipid A is cubic (7). Therefore, these data allow us to conclude
that the aggregate structure of the lipid A from the mutant
FIG. 1. The LPS of B. abortus bvrS and bvrR mutants shows higher affinity for bactericidal cationic peptides and contains an altered lipid A.
(A) Binding of dansyl-polymyxin B by LPS from the wt and bvrS and bvrR mutant strains. LPS suspensions were incubated with increasing amounts
of dansyl-polymyxin B, and the fluorescence (RFU) at 480 nm was determined. (B) HPTLC analysis of lipid A acylation in the wt strain, bvrS and
bvrR mutant strains, and reconstituted bvrR strain. Lipid A was extracted from purified LPS preparations or from OM fragments (blebs). Lane
Ec contained lipid A of E. coli MLK53 controls: hexa-acylated, penta-acylated, and tetra-acylated. (C) Maximum of the peak position of the
symmetric stretching vibration s(CH2) versus temperature for the LPSs of the wt and bvrS and bvrR mutant strains in the absence or in the
presence of polymyxin B. (D) Synchrotron radiation small-angle X-ray diffraction patterns of lipid A wt and bvrS mutant strain incubated with
polymyxin B obtained at 40°C and high water content (90%). The logarithm of the scattering intensity (log I) is plotted versus the scattering vector
s (	 1/d, where d 	 spacing).
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strain is more significantly altered by polymyxin B than that of
the wt, in agreement with the data in Fig. 1A and C.
The BvrS/BvrR system does not regulate transcription of
genes involved in the biosynthesis of lipid A forms with very-
long-chain acyl groups. Analysis of the B. melitensis and B. suis
genome sequences (13, 56) reveals two ORFs (BMEI1111 and
BMEI1475) whose products display 95% and 66% similarity to
the rhizobial AcpXL, the specialized acyl carrier protein
involved in the synthesis of the very-long-chain fatty acids
(VLCFAs) (C2827OH and C3029OH) of rhizobial lipid A. More-
over, Brucella also contains an ORF (BMEI1115) coding for a
protein with 68% similarity to LpxXL, the AcpXL cognate
acyltransferase that links VLCFAs to the beta-hydroxyl groups
of tetra- or penta-acyl lipid A to generate the fully acylated
forms (for a recent review, see reference 33). Ferguson et al.
(19) recently found that the BacA protein, required for viru-
lence (41), affects the VLCFA content of B. abortus lipid A. To
determine whether the lipid A alterations reflect a deregulated
transcription of those genes in the bvrR and bvrS mutants,
RT-PCR experiments were performed with oligonucleotide
primers specific for BMEI1111 and BMEI1475 (acpXL),
BMEI1115 (lpxXL), and bacA. The same profiles and band
intensities were obtained with the cDNA of the parental wt
strain and the bvrS and bvrR mutants (not shown), demonstrat-
ing that transcription of these ORFs was not regulated by
BvrS/BvrR.
The changes in the LPS of bvrS and bvrR mutants do not
alter cytokine induction. It is known that the biological activity
of Brucella LPS is lower than that of its enterobacterial coun-
terparts (50, 54). Also, some gram-negative bacteria are able to
shift lipid A acylation, thus reducing the biological potency of
the LPS and the responses of the innate and adaptive immune
systems. Therefore, we tested if the LPSs of the bvrS and bvrR
mutants had the same potency in triggering the generation of
macrophage cytokines as wt Brucella LPS. TNF- plays a major
role in coordinating the inflammatory response and activating
the cytokine cascade. Studies in vitro and in vivo demonstrate
that TNF- is a potent inducer of other cytokines, including
IL-10, which has the function of downregulating and control-
ling proinflammatory responses. Similarly, IL-12p40 plays an
important role in the normal host defense against infection by
a variety of intracellular microorganisms, including Brucella.
These three cytokines are secreted by macrophages in re-
sponse to canonical LPSs (e.g., Salmonella), and their kinetics
and secretion have been well established and used to deter-
mine the level of macrophage activation (54, 69). Consistent
with previous reports, considerable quantities of Brucella LPS
were required to induce the same level of activity as a standard
enterobacterial LPS (Fig. 3). However, no differences in the
induction of TNF-, IL-12p40, or IL-10 between the mutant
and wt LPSs were detected, supporting the concept that un-
FIG. 2. Effect of polymyxin B on the viability of B. abortus chimeras. (A) wt and chimeric bacteria were exposed to increasing amounts of
polymyxin B for 60 min at 37°C, and viability was assessed by plating on tryptic soy agar plates. Each experiment was run in triplicate, and the
standard error at each point was less than 5% of the value. (B) Electron microscopy of polymyxin B-treated bacteria. Panels 1 and 2, untreated
controls; 3 to 6, bacteria treated with 100 units of polymyxin B. The B. abortus wt strain (panels 1 and 3), bvrS mutant (panels 2 and 4), wt strain/bvrS
mutant LPS chimera (panel 5), and bvrS mutant/wt strain LPS chimera (panel 6) are shown. The inserts in panels 4 and 5 show (150,000) rolling
of the inner membrane and blebbing. Arrowheads in panels 4, 5, and 6 show OM blebbing.
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deracylated Brucella lipid A does not have any influence on the
biological activity.
Surface hydrophobicity and killing by nonimmune serum
are increased by BvrS/BvrR dysfunction. Surface hydropho-
bicity is a property that depends on the topology of the OM
surface. As mentioned above, the bvrS and bvrR mutants do
not express some Omps (30) that are both exposed on the
surface (11) and tightly bound to LPS (24, 58). Thus, we tested
surface hydrophobicity changes that could reveal a deeply al-
tered OM surface topology. In solvent partition experiments, it
was observed that the optical density of a suspension of the wt
strain decreased 19.0%  3.6% upon xylene extraction,
whereas the decreases were 45.2%  2.5% and 39.3% 
13.9% for the bvrS and bvrR mutant suspensions, respectively.
This twofold-higher partition into the organic solvent demon-
strates a higher surface hydrophobicity.
Smooth wt Brucella organisms are resistant to killing by
nonimmune serum, an activity that denotes the ability of com-
plement or associated collectins to recognize bacterial sur-
faces. The OM alterations of bvrS and bvrR mutants led us to
test whether resistance to serum was also diminished. Figure 4
shows that both mutants were markedly more sensitive to non-
immune bovine serum than the parental wt strain, and similar
results were obtained with human serum (data not shown). It
is noteworthy that their sensitivity was even higher than that of
sibling mutants with mutations in the genes per and manBcore
carrying rough LPSs with no O-polysaccharide and complete
or deeply truncated core oligosaccharides, respectively (49).
To investigate if this feature was related to the lipid A acyl-
chain shift, the complement-dependent hemolytic activity re-
maining after incubation of the LPSs of the mutant and wt
strains in serum aliquots with fixed amounts of complement
was assessed. The experiments showed that complement acti-
vation by the LPS of the mutants was not significantly altered
(hemolytic activities 21%, 23%, and 25% of those of controls
incubated without LPS for the bvrS and bvrR mutants and wt
strain LPSs, respectively).
DISCUSSION
The B. abortus BvrS/BvrR system regulates the expression of
at least two group 3 Omps, while other major Omps are not
affected (30). Here, we have extended our observations and
demonstrated that the lipid A moiety of the LPSs of the bvrS
and bvrR mutants displays an altered acylation pattern com-
pared to the parental strain, with the presence of underacy-
lated forms. However, whereas Omp25 and Omp22 are tran-
scriptionally regulated by BvrS/BvrR (30), transcription of
BMEI1115 (lpxXL homologue), BMEI1111, and BMEI1475
(acpXL homologues) was not altered by dysfunction of the
system. Since these are the only Brucella ORFs with homology
to acyltransferase genes involved in lipid A biosynthesis or to
acyl-carrier protein genes (33), a transcriptional regulation of
lipid A acylation by BvrS/BvrR seems unlikely. Similarly, tran-
scription of bacA remained unaffected. Thus, there is no obvi-
ous direct link between BvrS/BvrR and BacA. Disruption of
bacA leads to the dominance of underacylated lipid A forms
lacking mostly VLCFAs (19), and BacA shows sequence sim-
ilarity to a family of peroxisomal membrane proteins affecting
transport of activated VLCFAs out of the cytoplasm. On these
bases, Ferguson et al. (19) proposed that BacA could be in-
volved in exporting VLCFAs (and possibly other fatty acids)
out of the cytoplasm where a hypothetical protein similar to
Salmonella OM PagP (see below) could link them to lipid A.
An alternative proposed by the same authors is that BacA
could be necessary in the inner membrane for flipping the LPS
precursors carrying VLCFAs. Accordingly, in the absence of
BacA, translocation of underacylated forms lacking VLCFAs
would be favored owing to their comparatively lower hydro-
FIG. 3. Cytokine induction by LPSs in murine bone marrow-de-
rived macrophages. Macrophages were incubated with the indicated
concentrations of LPS for 48 h, supernatants were collected, and the
concentration of cytokines was determined by enzyme-linked immu-
nosorbent assay. LPSs were obtained from Shigella flexneri serotype 5a,
the B. abortus (Ba) wt, and the B. abortus bvrS mutant.
FIG. 4. Mutants in the two-component system BvrS/BvrR are
markedly sensitive to nonimmune serum. The survival of the B. abortus
wt, bvrS mutant, bvrR mutant, reconstituted bvrR strain, and rough
LPS mutant per and deep-rough LPS mutant manBcore strains in non-
immune bovine serum at 37°C is shown.
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phobicity. Although our results rule out transcriptional control
over bacA, these hypotheses may also apply to BvrS/BvrR. It is
conceivable that this system modulates the activity of some
inner membrane or OM protein necessary to incorporate
VLCFAs on the periplasmic side or that an altered OM topol-
ogy hampers translocation of the more hydrophobic LPS
forms. Concerning the first hypothesis, Brucella does not con-
tain homologues of PagP (33), but this is not necessarily mean-
ingful because the C16 acyl-chain substrate of PagP is markedly
different from the VLCFAs. The second hypothesis is consis-
tent with the observation that underacylated forms were en-
riched in the OM fragments because these fragments probably
represent the detachment of zones where new materials are
being rapidly incorporated into the OM (23). LPS and Omp25
form very hydrophobic, detergent-resistant complexes in OM
fragments (24). Therefore, it is plausible that the absence of
Omp25 in bvrS and bvrR mutants would somehow hamper
insertion of the fully acylated, more hydrophobic LPS forms
into the OM. However, B. abortus mutants carrying Omp25
deletions do not show enrichment of underacylated LPS (I.
Lo´pez-Gon˜i, unpublished results), and this shows that this
simplification of the second hypothesis cannot account for our
observations. Lipid A acylation patterns similar to those de-
scribed here have been observed in rough LPS mutants of B.
abortus (49) and other gram-negative bacteria (37), and it has
been proposed that this underacylation is a mechanism to
counterbalance the lack of the hydrophilic O-polysaccharide
(49). This pleiotropic effect illustrates that surface alterations
can also cause lipid A changes by compensatory mechanisms
and not necessarily by direct regulation. In this respect, it may
be relevant that the surface hydrophobicity of the bvrS and
bvrR mutants was increased, perhaps due to the absence of key
Omps. Since optimal OM stability requires a hydrophilic-to-
hydrophobic equilibrium, lipid A underacylation may be an
indirect counterbalancing adjustment.
It is well known that modifications of the lipid A moiety are
used by some gram-negative bacteria for pathogenesis (2, 18,
25, 26, 28, 29, 32, 57). The best-studied case is that of Salmo-
nella enterica serovar Typhimurium, where the lipid A is mod-
ified in response to host signals and sensed and modulated by
a two-component regulatory network controlling over 40 genes
(64). The essential components of this network are the PhoP/
PhoQ and PmrA/PmrB systems, both involved in resistance to
bactericidal cationic peptides and virulence (47, 48). Among
the lipid A modifications observed in Salmonella are the addi-
tion of arabinosamine or phosphoethanolamine to the diami-
noglucose backbone, the replacement of myristate with 2-OH
myristate, and the addition of palmitate catalyzed by PagP
(26–29, 31, 67, 70). Given their connection with virulence,
polycationic peptide sensitivity, and lipid A modification, it
may seem that the Brucella BvrS/BvrR and the S. enterica
serovar Typhimurium PhoP/PhoQ or PmrA/PmrB systems rep-
resent functional counterparts. However, several lines of evi-
dence demonstrate that the Brucella and S. enterica serovar
Typhimurium systems differ widely. First, as described previ-
ously (63), these genes bear little sequence similarity, and we
show here that BvrS/BvrR has no direct control on the genes
putatively involved in the generation of the fully acylated lipid
A forms of B. abortus or in obvious lipid A backbone or core
modifications. Second, none of the three Brucella genomes
sequenced so far contains genes homologous to the pmrJ,
pmrM, and pmrD genes involved in lipid A backbone arabi-
nosamine substitutions, and the genes homologous to other
genes of the Salmonella pmrHFIJKLM operon (regulated by
PhoP-PhoQ and PmrA-PmrB through pmrD) or to Salmonella
pmrE are not organized in an operon but scattered in both
chromosomes (33). Furthermore, in contrast to the 30 to 40%
relative increase in E-selectin and TNF- expression mani-
fested by the LPSs of a PhoP mutant (28), the biological
activity of the LPS from the bvrS mutant was not significantly
altered. As discussed elsewhere, an altered pathogen-associ-
ated molecular pattern not easily recognized by the innate
immune system is a constitutive trait of B. abortus LPS (54) and
not an environmentally modulated adaptive property. Thus, it
is not surprising that the mode of action of BvrS/BvrR departs
from the systems described in Enterobacteriaceae or Pseudo-
monadaceae (18).
Although the mechanism behind the appearance of under-
acylated LPSs remains to be elucidated, this structural shift
and the altered Omp profile explain several properties of the
bvrS and bvrR mutants, some clearly relevant to attenuation.
First, underacylation correlated with both higher polymyxin B
binding and augmented acyl-chain fluidity in LPS/lipid A ag-
gregates (Fig. 1A, C, and D), observations that are directly
connected. It is postulated that many bactericidal polycationic
peptides act on membranes by a self-promoted mechanism in
which an initial ionic interaction on the surface is followed by
the insertion of the hydrophobic peptide section(s). Accord-
ingly, the reduced lipid A hydrophobicity and the concomitant
increase in acyl-chain fluidity should ease insertion and pene-
tration of these peptides with a further increase in fluidity, as
observed. Thus, although a lack of shielding of the LPS by
Omp25 (not expressed in the mutants) could also contribute,
the lipid A structural shift explains at least in part the increased
sensitivity of mutant bacteria (63), as illustrated in the chimera
experiments (Fig. 2). Second, the higher sensitivity of the bvrS
and bvrR mutants to surfactants (63) is another phenotype
possibly explained by our observations since a correlation be-
tween OM permeability and LPS acyl-chain fluidity has been
observed previously (2, 3). Third, sensitivity to the bactericidal
action of normal sera is a serious handicap for a pathogen.
Since the bvrS and bvrR mutants have reduced ability to pen-
etrate into host cells (63) and are thus exposed to humoral host
defenses, their marked serum sensitivity undoubtedly contrib-
utes to their exceedingly rapid clearance from experimentally
infected animals (63). It is remarkable that the sensitivity of
bvrS and bvrR mutants to normal serum was higher than that of
rough LPS mutants with complete or deeply truncated core
and underacylated lipid A’s (49). This suggests that the lipid A
changes are not directly connected to the sensitivity to serum
complement, and this interpretation is supported by the dem-
onstration that LPS purified from the mutants did not display
higher complement-activating activity than the wt LPS.
In summary, we have shown that BvrS/BvrR dysfunction
weakens the overall stability of the B. abortus OM which be-
comes sensitive to humoral effectors (bactericidal peptides and
complement) of the innate immune system. In Brucella, as well
as in the intracellular pathogen Legionella, the lipid A is highly
hydrophobic, mainly because of the presence of the VLCFAs
that, in addition, are likely to span the OM, lending further
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stability to this structure. This ancestral property of some eu-
karyote-associated - and -Proteobacteria may represent an
advantage in the adaptation to intracellular parasitism (54).
The phenotypic effects of the lipid A shift of BacA and BvrS/
BvrR mutants lend further support to this hypothesis. Indeed,
overall OM homeostasis is not the sole aspect of Brucella
modulated by BvrS/BvrR, as this system is likely to be con-
nected with other aspects of the biology of the microbe, in-
cluding the regulation of some metabolic pathways (40, 43).
Experiments are under way to identify all of the Brucella genes
regulated by the two-component system BvrS/BvrR and their
relationship to the intracellular life of these pathogenic bacte-
ria.
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